Skip to main content
Clinical Trials/NCT06302205
NCT06302205RecruitingNot Applicable

A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise Intensity - a Monocenter Randomized Controlled Trial [PHOENIX-Liver]

Universitaire Ziekenhuizen KU Leuven2 sites in 1 country147 target enrollmentStarted: March 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
147
Locations
2
Primary Endpoint
Cardiorespiratory fitness

Study Overview

Brief Summary

Research demonstrated that transplant recipients benefit from physical activity, but there is a gap in knowledge regarding the required intensity. In the PHOENIX-Liver study, researchers aim to investigate the adequate intensity of rehabilitation programs after liver transplantation. Patients will be randomized into one of the three PHOENIX-Liver training groups (low, moderate, moderate to high). The six months rehabilitation program is conducted from the patient's home but supervised by a PHOENIX-investigator.

At baseline, after three months of rehabilitation and after six months of rehabilitation, a test moment takes place at which physical fitness, cardiovascular health, liver function, and body composition will be assessed. Questionnaires are taken monthly to survey well-being, safety, quality of life, physical activity, and cost-effectiveness.

To gather information on the potential for implementation in a real-world setting, a 15-month-long physical activity phase will start after the intervention phase. This entails a maintenance physical activity program tailored to the patients' preferences. A follow-up at UZ Leuven is planned at three and at 15 months where the same clinical evaluations will be conducted as during the test moments of the intervention phase.

Detailed Description

Liver transplantation constitutes the only curative treatment for patients with end-stage liver disease. Advances in the field have led to favourable short- and medium term (1-3 year) post-transplant survival rates, but improvement in long-term survival rates remains disappointing. Due to the immunosuppressive therapy, a sedentary lifestyle and a poor recovery of post-transplant physical fitness, the proportion of liver transplant recipients that develop a new-onset or a deteriorating unfavourable cardiovascular risk profile is alarmingly high, and cardiovascular disease is the leading cause of death in this population. By consequence, in order to improve long-term outcome after liver transplantation, prevention of cardiovascular disease should be prioritized. The investigators are convinced that the challenge of cardiovascular disease and lack of physical fitness in liver transplant recipients should and can be addressed by subjecting these patients to a structured physical rehabilitation program. The aim of this project is implement a structured, individually-tailored, home-based but supervised physical rehabilitation and maintenance program for de novo liver transplantation recipients, and to demonstrate the feasibility and safety of such approach as well as its efficacy to improve physical fitness. The program will consist of a 2-phase intervention of i) home-based exercise training (aerobic exercise training as well as strength, flexibility and stability exercises under in-person and subsequently remote guidance) and ii) an 15-month maintenance phase of physical activity. This program will be studied in an open-label randomized trial where the regimen will be compared with a regimen of standard of posttransplant care. In addition to the interventional arm, two different regimens of exercise training intensity will also be studied.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

The nature of the intervention does not allow blinding of study participants. However, outcome assessors and data investigators will be blinded to the participants' group allocation.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • de novo adult liver transplant recipients with a transplant vintage of two to three months
  • access to a home freezer (± -18°C)

Exclusion Criteria

  • Aberrant CPET (abnormal low cardiorespiratory fitness is not considered an exclusion criteria), unstable angina, life-threatening arrhythmias, uncontrolled hypertension/diabetes, HbA1c ≥ 9%, severe pulmonary disease (FEV1 < 50%), musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise
  • multi-organ transplantation (exception: combined liver-kidney transplant is considered eligible for participation)
  • ongoing treatment for malignancies
  • unable to understand Dutch
  • no access to smartphone and/or computer with internet access
  • does not willing to except the general conditions of Coachbox. Preparticipation medical screening (cardiopulmonary exercise testing with 12-lead ECG + stratification of cardiovascular risk factors) will be performed by a cardiologist (Dr. Kaatje Goetschalckx at UZ Leuven).

Outcomes

Primary Outcomes

Cardiorespiratory fitness

Time Frame: At 0, 3 and 6 months of the interventional rehabilitation programme and at 15 months after the end of the intervention

Changes in peak oxygen uptake (mL O2·min-1·kg-1) assessed by cardiopulmonary exercise test

Secondary Outcomes

  • Graft function(At 0 and after 21 months)
  • Blood pressure(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Blood profile(At 0, 3 and 6 months of the interventional rehabilitation programme, and at 3 and 15 months after the end of the intervention)
  • Hand grip strength(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Functional exercise capacitiy(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Arterial stiffness(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Motor fitness(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Endothelial function(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Knee-extensor strength(At 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the intervention)
  • Occurence of adverse events(Monthly)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials